| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 13.3. Anti-inflammatory and antipruritic medicines |
Age or weight restriction:
Hydrocortisone preferred in neonates. Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (D07AC Corticosteroids, potent (group III)). |
| Bolivia | LINAME 2011 - 2013 | No observations |
| Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia | 10.5 Corticosteroids | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| List | Section | Observation |
|---|---|---|
| Bolivia | LINAME 2011 - 2013 | No observations |
| List | Section | Observation |
|---|---|---|
| Colombia | 08.3 Systemic Corticosteroids | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 13.3. Anti-inflammatory and antipruritic medicines |
Age or weight restriction:
Hydrocortisone preferred in neonates. Others observations: Therapeutic alternatives: 4th level ATC chemical subgroup (D07AC Corticosteroids, potent (group III)). |
| List | Section | Observation |
|---|---|---|
| Colombia | 10.5 Corticosteroids | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |
| List | Section | Observation |
|---|---|---|
| Chile | Essential and Prioritized Medications | No observations |